telomeres; telomerase inhibitor; G-quadruplex; noncovalent; DNA; mass spectrometry
Abstract :
[en] Ascididemin and Meridine are two marine compounds with pyridoacridine skeletons known to exhibit interesting antitumour activities. These molecules have been reported to behave like DNA intercalators. In this study, dialysis competition assay and mass spectrometry experiments were used to determine the affinity of ascididemin and meridine for DNA structures among duplexes, triplexes, quadruplexes and single-strands. Our data confirm that ascididemin and meridine interact with DNA but also recognize triplex and quadruplex structures. These molecules exhibit a significant preference for quadruplexes over duplexes or single-strands. Meridine is a stronger quadruplex ligand and therefore a stronger telomerase inhibitor than ascididemin (IC50= 11 and > 80 mu M, respectively in a standard TRAP assay). (c) 2005 Elsevier B.V. All rights reserved.
Research Center/Unit :
CART - Centre Interfacultaire d'Analyse des Résidus en Traces - ULiège
E. Delfourne, and J. Bastide Marine pyridoacridine alkaloids and synthetic analogues as antitumour agents Med. Res. Rev. 23 2003 234 252
F.J. Schmitz, F.S. De Guzman, M.B. Hossain, and D. van der Helm Cytotoxic aromatic alkaloid from the ascidian Amphicarpa meridiana and Leptoclinides sp.: Meridine and 11-hydroxyascididemin J. Org. Chem. 56 1991 804 808
J. Kobayashi, J. Cheng, H. Nakamura, and Y. Ohizumi Ascididemin, a novel pentacyclic aromatic alkaloid with potent antileukemic activity from the okinawan tunicate Didemnum sp. Tetrahedron Lett. 29 1988 1177 1180
S.S. Matsumoto, M.H. Sidford, J.A. Holden, L.R. Barrows, and B.R. Copp Mechanism of action studies of cytotoxic marine alkaloids: ascididemin exhibits thiol-dependant oxidative DNA cleavage Tetrahedron Lett. 41 2000 1667 1670
I. Bonnard, N. Bontemps, S. Lahmi, B. Banaigs, G. Combaut, C. Francisco, P. Colson, C. Houssier, M. Waring, and C. Bailly Binding to DNA and cytotoxic evaluation of ascididemin, the major alkaloid from the Mediterranean ascidian Cystodytes dellechiajei Anti-Cancer Drug Des. 10 1995 333 346
A. Rich DNA comes in many forms Gene 135 1993 99 109
M. Mills, L. Lacroix, P. Arimondo, J.L. Leroy, J.C. François, H.H. Klump, and J.L. Mergny Unusual DNA conformations: implications for telomeres Curr. Med. Chem., Anti-Cancer Agents 2 2002 627 644
J.R. Williamson G-quartet structures in telomeric DNA Annu. Rev. Biophys. Biomol. Struct. 23 1994 703 730
J.T. Davis G-quartets 40 years later: from 5′-GMP to molecular biology and supramolecular chemistry Angew. Chem., Int. Ed. 43 2004 668 698
K. Masutomi, E.Y. Yu, S. Khurts, I. BenPorath, J.L. Currier, G.B. Metz, M.W. Brooks, S. Kaneko, S. Murakami, J.A. DeCaprio, R.A. Weinberg, S.A. Stewart, and W.C. Hahn Telomerase maintains telomere structure in normal human cells Cell 114 2003 241 253
Y. Wang, and D.J. Patel Solution structure of the human telomeric repeat d[AG3(T2AG3)3] G-Tetraplex Structure 1 1993 263 282
G.N. Parkinson, M.P.H. Lee, and S. Neidle Crystal structure of parallel quadruplexes from human telomeric DNA Nature 417 2002 876 880
A.M. Zahler, J.R. Williamson, T.R. Cech, and D.M. Prescott Inhibition of telomerase by G-quartet DNA structures Nature 350 1991 718 720
D. Sun, B. Thompson, B.E. Cathers, M. Salazar, S.M. Kerwin, J.O. Trent, T.C. Jenkins, S. Neidle, and L.H. Hurley Inhibition of human telomerase by a G-quadruplex-interactive compound J. Med. Chem. 40 1997 2113 2116
J.L. Mergny, and C. Hélène G-quadruplex DNA: a target for drug design Nat. Med. 4 1998 1366 1367
J.L. Mergny, J.F. Riou, P. Mailliet, M.P. Teulade-Fichou, and E. Gilson Natural and pharmacological regulation of telomerase Nucleic Acids Res. 30 2002 839 865
G. Saretzki Telomerase inhibition as cancer therapy Cancer Lett. 194 2003 209 219
E.M. Rezler, D.J. Bearss, and L.H. Hurley Telomere inhibition and telomere disruption as processes for drug targeting Annu. Rev. Pharmacol. Toxicol. 43 2003 359 379
J. Cuesta, M. Read, and S. Neidle The design of G-quadruplex ligands as telomerase inhibitors Mini Rev. Med. Chem. 3 2003 11 21
P.T. Rowley Development of telomerase inhibitors Expert Opin. Ther. Pat. 11 2001 1815 1823
S.M. Kerwin G-quadruplex DNA as a target for drug design Curr. Pharm. Des. 6 2000 441 471
L. Guittat, P. Alberti, D. Gomez, A. de Cian, G. Pennarun, T. Lemarteleur, C. Belmokhtar, R. Paterski, H. Morjani, C. Trentesaux, E. Mandine, F. Boussin, P. Mailliet, L. Lacroix, J.-F. Riou, and J.-L. Mergny Targeting human telomerase for cancer therapeutics Cytotechnomogy 45 2004 75 90
L. Guittat, P. Alberti, F. Rosu, S. Van Miert, E. Thetiot, L. Pieters, V. Gabelica, E. De Pauw, A. Ottaviani, J.F. Riou, and J.-L. Mergny Interactions of cryptolepine and neocryptolepine with unusual DNA structures Biochimie 85 2003 535 547
K. Shin-ya, K. Wierzba, K. Matsuo, T. Ohtani, Y. Yamada, K. Furihata, Y. Hayakawa, and H. Seto Telomestatin, a novel telomerase inhibitor from Streptomyces anulatus J. Am. Chem. Soc. 123 2001 1262 1263
M.Y. Kim, H. Vankayalapati, K. Shin-Ya, K. Wierzba, and L.H. Hurley Telomestatin, a potent telomerase inhibitor that interacts quite specifically with the human telomeric intramolecular G-quadruplex J. Am. Chem. Soc. 124 2002 2098 2099
S. Gowan, R. Heald, M. Stevens, and L. Kelland Potent inhibition of telomerase by small-molecule pentacyclic acridines capable of interacting with G-quadruplexes Mol. Pharmacol. 60 2001 981 988
F. Bracher Total synthesis of the pentacyclic alkaloid ascididemin Heterocycles 29 1989 2093 2095
N. Bontemps, E. Delfourne, J. Bastide, C. Francisco, and F. Bracher Total synthesis of the marine pentacyclic alkaloid meridine Tetrahedron 53 1997 1743 1750
C.R. Cantor, M.M. Warshaw, and H. Shapiro Oligonucleotide interactions. 3. Circular dichroism studies of the conformation of deoxyoligonucleotides Biopolymers 9 1970 1059 1077
J.S. Ren, and J.B. Chaires Sequence and structural selectivity of nucleic acid binding ligands Biochemistry 38 1999 16067 16075
J.S. Ren, and J.B. Chaires Rapid screening of structurally selective ligand binding to nucleic acids J.B. Chaires M.J. Waring Drug Nucleic Acid Interaction 2001 Academic Press Inc. 525 B Street, Suite 1900, San Diego, CA 92101-4495, USA 99 108
J.B. Chaires, J. Ren, D. Hamelberg, A. Kumar, V. Pandya, D.W. Boykin, and W.D. Wilson Structural selectivity of aromatic diamidines J. Med. Chem. 47 2004 5729 5742
F. Rosu, E.D. Pauw, L. Guittat, P. Alberti, L. Lacroix, P. Mailliet, J.-F. Riou, and J.-L. Mergny Selective interaction of ethidium derivatives with quadruplexes Biochemistry 42 2003 10361 10371
J.L. Mergny, and J.C. Maurizot Fluorescence resonance energy transfer as a probe for G-quartet formation by a telomeric repeat ChemBioChem 2 2001 124 132
J.L. Mergny, L. Lacroix, M.P. Teulade-Fichou, C. Hounsou, L. Guittat, M. Hoarau, P.B. Arimondo, J.P. Vigneron, J.M. Lehn, J.F. Riou, T. Garestier, and C. Hélène Telomerase inhibitors based on quadruplex ligands selected by a fluorescent assay Proc. Natl. Acad. Sci. U. S. A. 98 2001 3062 3067
J. Beck, M.L. Colgrave, S.F. Ralph, and M.M. Sheil Electrospray ionization mass spectrometry of oligonucleotide complexes with drugs, metals, and proteins Mass Spectrom. Rev. 20 2001 61 87
V. Gabelica, E. DePauw, and F. Rosu Interaction between antitumor drugs and a double-stranded oligonucleotide studied by electrospray ionization mass spectrometry J. Mass Spectrom. 34 1999 1328 1337
F. Rosu, V. Gabelica, C. Houssier, P. Colson, and E. De Pauw Triplex and quadruplex DNA structures studied by electrospray mass spectrometry Rapid Commun. Mass Spectrom. 16 2002 1729 1736
J.L. Mergny, A.T. Phan, and L. Lacroix Following G-quartet formation by UV-spectroscopy FEBS Lett. 435 1998 74 78
J.S. Ren, and J.B. Chaires Preferential binding of 3,3′- diethyloxadicarbocyanine to triplex DNA J. Am. Chem. Soc. 122 2000 424 425
A.T. Phan, and D.J. Patel Two-repeat human telomeric d(TAGGGTTAGGGT) sequence forms interconverting parallel and antiparallel G-quadruplexes in solution: distinct topologies, thermodynamic properties, and folding/unfolding kinetics J. Am. Chem. Soc. 125 2003 15021 15027
P. Balagurumoorthy, and S.K. Brahmachari Structure and stability of human telomeric sequence J. Biol. Chem. 269 1994 21858 21869
R.T. Wheelhouse, D. Sun, H. Han, F.X. Han, and L.H. Hurley Cationic porphyrins as telomerase inhibitors: the interaction of tetra (N-methyl-4-pyridyl) porphyrin with quadruplex DNA J. Am. Chem. Soc. 120 1998 3261 3262
O.Y. Fedoroff, M. Salazar, H. Han, V.V. Chemeris, S.M. Kerwin, and L.H. Hurley NMR-based model of a telomerase inhibiting compound bound to G-quadruplex DNA Biochemistry 37 1998 12367 12374
P.J. Perry, M.A. Read, R.T. Davies, S.M. Gowan, A.P. Reszka, A.A. Wood, L.R. Kell, and S. Neidle 2,7-disubstituted amidofluorenone derivatives as inhibitors of human telomerase J. Med. Chem. 42 1999 2679 2684
R.J. Harrison, S.M. Gowan, L.R. Kell, and S. Neidle Human telomerase inhibition by substituted acridine derivatives Bioorg. Med. Chem. Lett. 9 1999 2463 2468
S. Neidle, R.J. Harrison, A.P. Reszka, and M.A. Read Structure-activity relationships among guanine-quadruplex telomerase inhibitors Pharmacol. Ther. 85 2000 133 139
V. Caprio, B. Guyen, Y. Opoku-Boahen, J. Mann, S.M. Gowan, L.M. Kelland, M.A. Read, and S. Neidle A novel inhibitor of human telomerase derived from 10 H-indolo[3,2-b]quinoline Bioorg. Med. Chem. Lett. 10 2000 2063 2066
F. Koeppel, J.F. Riou, A. Laoui, P. Mailliet, P.B. Arimondo, D. Labit, O. Petigenet, C. Hélène, and J.L. Mergny Ethidium derivatives bind to G-quartets, inhibit telomerase and act as fluorescent probes for quadruplexes Nucleic Acids Res. 29 2001 1087 1096
S. Missailidis, J. Stanslas, C. Modi, M.J. Ellis, R.A. Robins RA, C.A. Laughton, and M.F. Stevens Antitumor polycyclic acridines. Part 12. Physical and biological properties of 8,13-diethyl-6-methylquino[4,3,2-kl]acridinium iodide: a lead compound in anticancer drug design Oncol. Res. 13 2002 175 189
P. Alberti, P. Schmidt, C.H. Nguyen, M. Hoarau, D. Grierson, and J.L. Mergny Benzoindoloquinolines interact with DNA quadruplexes and inhibit telomerase Bioorg. Med. Chem. Lett. 12 2002 1071 7074
D.F. Shi, R.T. Wheelhouse, D.Y. Sun, and L.H. Hurley Quadruplex- interactive agents as telomerase inhibitors: synthesis of porphyrins and structure-activity relationship for the inhibition of telomerase J. Med. Chem. 44 2001 4509 4523
R.A. Heald, C. Modi, J.C. Cookson, I. Hutchinson, C.A. Laughton, S.M. Gowan, L.R. Kell, and M.F.G. Stevens Antitumor polycyclic acridines. 8. Synthesis and telomerase-inhibitory activity of methylated pentacyclic acridinium salts J. Med. Chem. 45 2002 590 597
S.M. Gowan, J.R. Harrison, L. Patterson, M. Valenti, M.A. Read, S. Neidle, and L.R. Kelland A G-quadruplex-interactive potent small-molecule inhibitor of telomerase exhibiting in vitro and in vivo antitumor activity Mol. Pharmacol. 61 2002 1154 1162
L. Rossetti, M. Franceschin, A. Bianco, G. Ortaggi, and M. Savino Perylene diimides with different side chains are selective in inducing different G-quadruplex DNA structures and in inhibiting telomerase Bioorg. Med. Chem. Lett. 12 2002 2527 2533
M. Read, R.J. Harrison, B. Romagnoli, F.A. Tanious, S.H. Gowan, A.P. Reszka, W.D. Wilson, L.R. Kell, and S. Neidle Structure-based design of selective and potent G quadruplex-mediated telomerase inhibitors Proc. Natl. Acad. Sci. U. S. A. 98 2001 4844 4849
A. Maraval, S. Franco, C. Vialas, G. Pratviel, M.A. Blasco, and B. Meunier Porphyrin-aminoquinoline conjugates as telomerase inhibitors Org. Biomol. Chem. 1 2003 921 927
R.J. Harrison, J. Cuesta, G. Chessari, M.A. Read, S.K. Basra, A.P. Reszka, J. Morrell, S.M. Gowan, C.M. Incles, F.A. Tanious, W.D. Wilson, L.R. Kell, and S. Neidle Trisubstituted acridine derivatives as potent and selective telomerase inhibitors J. Med. Chem. 46 2003 4463 4476
F. Rosu, V. Gabelica, K. Shin-ya, and E. DePauw Telomestatin induced stabilization of the human telomeric DNA quadruplex monitored by electrospray mass spectrometry Chem. Commun. 34 2003 2702 2703
T. Lemarteleur, D. Gomez, R. Paterski, E. Mandine, P. Mailliet, and J.-F. Riou Stabilization of the c-myc gene promoter quadruplex by specific ligands inhibitors of telomerase Biochem. Biophys. Res. Commun. 323 2004 802 808
D. Gomez, R. Paterski, T. Lemarteleur, K. Shinya, J.L. Mergny, and J.F. Riou Interaction of telomestatin with the telomeric single-strand overhang J. Biol. Chem. 279 2004 41487 41494
T. Tauchi, K. Shinya, G. Sashida, M. Sumi, A. Nakajima, T. Shimamoto, J.H. Ohyashiki, and K. Ohyashiki Activity of a novel G-quadruplex-interactive telomerase inhibitor, telomestatin (SOT-095), against human leukemia cells: involvement of ATM-dependent DNA damage response pathways Oncogene 22 2003 5338 5347
A. Nakajima, T. Tauchi, G. Sashida, M. Sumi, K. Abe, K. Yamamoto, J.H. Ohyashiki, and K. Ohyashiki Telomerase inhibition enhances apoptosis in human acute leukemia cells: possibility of antitelomerase therapy Leukemia 17 2003 560 567
J.F. Riou, L. Guittat, E. Renou, P. Mailliet, A. Laoui, O. Petigenet, C. Hélène, and J.L. Mergny Cell senescence and telomere shortening induced by a new series of specific quadruplex DNA ligands. Proc. Natl. Acad. Sci. U. S. A. 99 2002 2672 2677
C. Leonetti, S. Amodei, C. DAngelo, A. Rizzo, B. Benassi, A. Antonelli, R. Elli, M.F.G. Stevens, M. DIncalci, G. Zupi, and A. Biroccio Biological activity of the G-quadruplex ligand RHPS4 (3,11-difluoro-6,8,13-trimethyl-8H- quino[4,3,2-kl]acridinium methosulfate) is associated with telomere capping alteration Mol. Pharmacol. 66 2004 1138 1146
E. Gavathiotis, R.A. Heald, M.F.G. Stevens, and M.S. Searle Drug recognition and stabilisation of the parallel-stranded DNA quadruplex d(TTAGGGT)(4) containing the human telomeric repeat J. Mol. Biol. 334 2003 25 36
